Search
Mediwound Ltd
MDWDAdd to Watchlist
13.300USD
-0.560-4.04%
Close 10-30 16:00（ET）
171.70MMarket Cap
LossP/E TTM
Mediwound Ltd (MDWD) Stock Price Target & Forecast
Analyst Rating
Based on 6 analysts giving stock ratings to Mediwound Ltd in the past month.
Buy
1 Strong Buy
5 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
30.667USD+126.16%
MDWD Analyst Recommendation Trends
In the current month, MDWD has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MDWD average Analyst price target in the last month is 30.667.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
1
1
1
1
1
1
1
1
5
5
5
5
5
5
5
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
6
6
6
6
6
6
6
MDWD Analyst Rating for Peer Comparison
Updated: Nov 1, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
10
17
10
1
0
38
Amgen Inc
AMGN
4
9
19
3
1
36
Eli Lilly and Co
LLY
10
19
3
1
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Alnylam Pharmaceuticals Inc
ALNY
5
18
9
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Merck & Co Inc
MRK
7
15
9
0
0
31
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Gilead Sciences Inc
GILD
7
18
5
0
0
30
Financial Forecasting
Based on analysts' estimates, MDWD EPS is projected to reach -0.707 in FY2026Q3, following reported EPS of -0.574 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.63
-0.66
-0.76
-0.71
-0.63
Actual
-0.56
-0.23
-0.57
--
--
Surprise
+11.48%
+64.99%
+24.67%
--
--
FAQs
What is Mediwound Ltd's expected revenue for the next quarter?
Mediwound Ltd's expected revenue is 6.73M.
What is Mediwound Ltd's price target?
Analysts forecast that Mediwound Ltd's price target is USD 30.67, with the highest forecast at USD 36.00 and the lowest forecast at USD 25.00.
How have Mediwound LtdMDWD's recent earnings per share performed?
The market expectation was USD -0.57, while Mediwound LtdMDWD's earnings per share (EPS) for the previous quarter was USD -0.23. EPS for the next quarter is expected at USD -0.71.
What is the analyst rating for Mediwound Ltd?
Based on the ratings of Mediwound Ltd's stock from 6 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.